Economic evaluation of non-pharmacological interventions for fatigue in patients with long-term medical conditions
Mon-Yee, M.; Burton, C.; Leaviss, J.; Forsyth, J. E.; Daly, G.; Davis, S.
Show abstract
BackgroundPersistent fatigue is a frequent symptom in chronic medical conditions. Systematic reviews of non-pharmacological interventions for fatigue have identified interventions that are effective at reducing fatigue, but there is limited published evidence on the cost-effectiveness of these interventions. ObjectiveTo identify non-pharmacological fatigue interventions that have the potential to be cost-effective and would warrant further investigation in future cost-effectiveness studies. DesignDecision-analytic modelling with quality-of-life outcomes mapped from a systematic review and network meta-analysis of fatigue outcomes and intervention costs estimated from staff time. SettingUK National Health Service (NHS) ParticipantsPeople with persistent fatigue associated with a chronic medical condition InterventionsNon-pharmacological fatigue interventions versus usual care Primary and secondary outcome measuresNet monetary benefit from a UK NHS and Personal Social Services (PSS) perspective; quality-adjusted life years (QALYs) gained; intervention costs valued at 2022/23 prices; costs and benefits discounted at 3.5% per annum. ResultsIn the base case analysis, expected costs from the probabilistic analysis for individual and group interventions were: {pound}267 and {pound}157 for physical activity promotion, {pound}810 and {pound}485 for CBT-Fatigue, and {pound}462 and {pound}214 for mindfulness. The expected QALYs gained were similar for mindfulness and physical activity promotion (0.061 and 0.060 respectively), but lower for CBT-Fatigue (0.045). All interventions provided positive incremental net monetary benefit (INMB) versus usual care when valuing a QALY at {pound}20,000. However, since group interventions are less costly than individual ones, and we assumed equivalent clinical benefit, they are expected to provide greater INMB. These findings remained robust across different scenarios, except for CBT-Fatigue (individual) which had negative INMB in some scenarios. ConclusionsCBT-Fatigue, physical activity promotion and mindfulness interventions all demonstrated the potential to be cost-effective versus usual care. Future research is recommended to compare the cost-effectiveness of these interventions across a broad population with different chronic conditions. STRENGTHS AND LIMITATIONS OF THIS STUDYO_LIFatigue outcomes were estimated from a robust systematic review and network analysis that pooled data across studies conducted across multiple chronic conditions, with multiple sclerosis being most common. C_LIO_LIThe treatment effects for interventions delivered to groups and individuals are assumed to be similar, but this assumption was only supported by an analysis exploring separate treatment effects for group and individual CBT-Fatigue interventions. C_LIO_LIThe results for group physical activity promotion and individual mindfulness interventions should be treated with caution owing to there only being data beyond end of treatment for individual physical activity promotion and group mindfulness interventions. C_LIO_LIHealthcare costs were restricted to staffing costs for delivering the intervention and therefore do not capture any impact on resource use outside of the intervention or any non-staff intervention cost such as access to a specific digital tool. C_LI
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol 93%
- Investigating the use of a one-page infographic to improve recruitment and retention to the BASIL+ Randomised Controlled Trial: A Study Within a Trial (SWAT) 92%
- A model framework for projecting the prevalence and impact of Long-COVID in the UK 91%
Similar papers in this journal
- Clinical And Cost-Effectiveness Of A Personalised Guided Consultation Versus Usual Physiotherapy Care In People Presenting With Shoulder Pain: A Protocol For The Panda-S Cluster Randomised Controlled Trial And Process Evaluation 91%
- Adverse effects of remdesivir, hydroxychloroquine, and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomized trials 91%
- A text messaging intervention to support patients with chronic pain during prescription opioid tapering: protocol for a double-blind randomised controlled trial 91%
Similar papers in this journal
Similar papers in this journal
- Global Burden of Covid-19 Restrictions: National, Regional and Global Estimates 90%
- Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19 89%
- Treatment decision algorithms for tuberculosis screening and diagnosis in children below 5 years hospitalised with severe acute malnutrition: a cost-effectiveness analysis 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.